- Tilray (TLRY) has launched its “Take Back Control” platform, which will connect women with free resources on medical cannabis
- Take Back Control will allow women to make informed decisions about medical cannabis
- It assists them along their path to discovering how medical cannabis can play a part in their daily healthcare practices
- Tilray Medical is the recognized global leader in medical cannabis
- Tilray Stock (TSX:TLRY) is down 3.33 per cent, trading at C$5.23 per share at 12:17 pm ET
Tilray (TLRY) has launched its “Take Back Control” platform, which will connect women with free resources on medical cannabis.
The new platform helps destigmatize the use of medical cannabis in women’s healthcare practices. It connects people with free consultations with healthcare practitioners focusing on women’s health, providing expert advice on medical cannabis.
Take Back Control will allow women to make informed decisions about medical cannabis. It assists them along their path to discovering how medical cannabis can play a part in their daily healthcare practices.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. It cultivates a wide range of strains to meet patient needs, including indicas, sativas, hybrids, and CBD-rich varieties. Medical cannabis is available in two primary forms: extracts and dried flower.
The company aims to help people take back control of their healthcare choices and treatment. It provides safe and reliable access to a portfolio of medical cannabis brands, including Tilray, Aphria, Broken Coast, and Symbios. The company’s production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and alcoholic beverages.